AI news videos

NVIDIA Says Startups In Its Inception Program Are Applying AI To Breast Cancer Care

NVIDIA published a post on its own blog describing how four startups in its Inception program are applying AI across breast cancer care, covering imaging, risk assessment and treatment prediction. The post is dated October 5, 2026.

Watch on YouTube

Transcript

Sources

Every claim in this video comes from the top ranking coverage of this topic. The claims and where each one came from:

• Backing sentences, quoted from the page: the standfirst "NVIDIA Inception companies are applying AI to each stage of the breast cancer care journey, imaging, risk assessment and treatment decisions." and "Companies in the NVIDIA Inception program for startups are building AI applications to support clinicians at each of these friction points, including imaging, risk assessment and treatment planning." NOTE ON QUOTING: the source sets off clauses with em dashes throughout, including in the standfirst, and a gate bars every dash form from every field of this file, so quoted source em dashes are rendered here as commas and the source's curly apostrophes are rendered as straight ASCII apostrophes. No word of the quoted text is otherwise altered. EDITORIAL DECISION: hook sentence one states the plainest fact of the post, that NVIDIA says startups are using AI in breast cancer care, and attributes it out loud with "NVIDIA says" because the claim is NVIDIA's own about companies in NVIDIA's own program. Hook sentence two, "The post appeared on NVIDIA's own blog", puts the provenance inside the first five seconds, which is required here because nothing on the page is checked by an outside party and no corroboration of any kind was obtainable. The hook is exactly two sentences, because the renderer splits the hook into two on-screen beats and a one sentence hook renders the second beat as undefined and forces a full voiceover redo. The hook is seventeen words, under the twenty word ceiling, and it speaks no figure at all, which keeps the script's single spoken figure out of the opening and off the hook card. The word "four" was deliberately cut from an earlier hook draft because a count is a figure and the hook must carry none. No calendar date is spoken anywhere in this script: the page's own date, October 5, 2026, lives only in storyDate. NOT NARRATED: the author's name and NVIDIA job title, the category and the four tags are real page facts held out of narration for budget; the author's role is carried on the scene 4 card because it is provenance. The standfirst's third item, "treatment decisions", is not spoken in the hook because a three item comma list is barred from narration. REFUSED: the headline is a figure of speech twice over, "From Scan to Treatment Plan" and "Close Breast Cancer's Deadliest Gaps", and neither is narrated or paraphrased into a new figure. The page's "friction points" and "the breast cancer care journey" are also figurative and are refused in every form. The superlative framing "Deadliest Gaps" is not narrated: the page offers no mortality data of any kind. Nothing in this script calls any of this a cure, a breakthrough in outcomes or a proven survival benefit, because the page shows none of that.(HOOK BACKING. First-party NVIDIA corporate blog post on blogs.nvidia.com, headlined "From Scan to Treatment Plan, AI Helps Close Breast Cancer's Deadliest Gaps", dated October 5, 2026 on the page itself, by Chelsea Sumner, whom the page identifies as "healthcare AI startups lead for North and Latin America at NVIDIA", filed under category AI and tags "AI for Good", "Healthcare and Life Sciences", "Inception" and "Physical AI". Captured by our news watcher at 2026-10-05T13:11:43.908Z and read for this script only from that saved snapshot; the manager independently re-fetched the live URL and reports the live page still matches the snapshot headline, date and body. This is NVIDIA writing on NVIDIA's own blog about four companies in NVIDIA's own Inception startup program, every one of which the page says runs on NVIDIA GPUs and NVIDIA software, so the page is the sole and self-interested source for every narrated claim in this Short. NVIDIA announced no product of its own here.)
• Backing sentences, quoted from the page: "About 40 million mammograms are performed in the U.S. each year, but a projected shortfall of tens of thousands of radiologists over the next decade is straining the system's capacity to read them." Card detail is backed by: "Breast cancer is the most commonly diagnosed cancer among American women, yet the gaps in care are wide. A majority of women over age 40 skip the recommended annual screening. Radiologists are reading more mammograms with fewer colleagues. And when a diagnosis arrives, the tests that inform treatment can take weeks to return results." and "treatment decisions often hinge on genomic assays sent off to outside labs, assays that take weeks to process". EDITORIAL DECISION: this scene carries the script's ONE spoken figure, "about forty million", spoken as words with no digits, because a gate bars digits from narration. It is the page's only clean scale number that is not a vendor performance claim about a vendor's own product, which makes it the safest single figure to speak. It is placed in scene 1 so that the hook before it, scenes 2 and 3 after it, scene 4 and the endcard are all completely figure free, which satisfies the rule that two spoken figures must be separated by at least one figure free sentence; in this script there is no second spoken figure at all, so the separation requirement is satisfied by a margin of three figure free sentences on one side and five on the other. That choice is deliberate and not merely conservative: our transcriber falls into a repetition loop when two figures are spoken close together and swallows the middle of the transcript, which costs a full render. "The United States" is spoken in full words because the voice engine is unreliable on short glued letter tokens, and "US" appears only on the silent card. The source sentence is a two clause sentence joined by "but"; only the first clause is spoken, which keeps the scene at fourteen words and one sentence, and the radiologist shortfall clause moves to the silent card where it costs zero seconds. NOT NARRATED: the projected shortfall of tens of thousands of radiologists, the claim that a majority of women over age 40 skip the recommended annual screening, the statement that breast cancer is the most commonly diagnosed cancer among American women, and the genomic assay turnaround are all real page facts dropped from narration for word budget and for the no spoken figure rules. "Tens of thousands" is itself a figure and could not be spoken in the same sentence as "forty million" under the adjacency rule, so it went to the card. REFUSED: the page's "the gaps in care are wide", "friction points", "at a moment when speed and certainty matter most" and "treatment decisions often hinge on" are figures of speech or editorial colour and are refused in narration in every form. The phrase "the system's capacity" is not narrated as a crisis claim. No urgency or countdown framing is used anywhere: "over the next decade" is kept off the card as a deadline style phrase and the card states the shortfall as a projection NVIDIA cites, with no date window attached.(SCENE 1 BACKING. Same first-party NVIDIA blog post, the opening context paragraphs. The scale and workforce statements are NVIDIA's own unsourced assertions: the page names no study, no registry, no agency and no publication behind any of them, and gives no methodology, date range or citation for the mammogram volume or the radiologist shortfall.)
• Backing sentences, quoted from the page: "The company's FDA-cleared ATUSA platform, a wearable, automated 3D quantitative ultrasound system, captures a standardized breast volume in approximately two minutes per breast, compared with up to 45 minutes for a conventional handheld ultrasound." and "The system's AI, trained on thousands of full-breast scans comprising over 1.5 million ultrasound frames, automates image acquisition. It uses NVIDIA GPU acceleration and open source medical imaging technology to deliver a 3D scan that the company says is 28% more sensitive than a handheld 2D ultrasound." and "Handheld ultrasound depends on whoever holds the probe, so a woman's scans typically can't be compared from one year to the next. ATUSA captures the whole breast the same way every time, creating a repeatable view of breast tissue that could help clinicians analyze how a patient's tissue changes across successive scans, while also reducing operator errors and variability." and "ATUSA is commercially available through partner clinics across California, Texas, Georgia, Tennessee and Washington D.C., with new sites coming online regularly." and "The company has a multicenter clinical study with 3,200 patients underway to further validate the platform's performance, with lead research sites at UC Davis and Vanderbilt University Medical Center." EDITORIAL DECISION: the narration is one sentence of thirteen words and speaks no figure, because the 28% is a vendor performance claim and the script's figure budget was spent in scene 1 on the page's neutral scale number. The claim is attributed out loud with "One company says", which mirrors the page's own hedge "that the company says" and keeps the assertion where it belongs, with the vendor. No brand name is spoken: "iSono Health", "ATUSA", "WRDensity" and the rest are invented brand names, glued brand plus letter tokens or dotted domain style names, all of which our voice engine garbles, so the company is referred to generically as "one company" and every real name is carried silently on the scene card. The 28%, the two minutes, the 45 minutes, the 1.5 million frames, the five state availability list and the 3,200 patient study are all on the silent card, where they cost zero seconds and carry no transcriber loop risk. The repeatability point, which is arguably the stronger and better evidenced claim on this part of the page, was cut from narration purely for word budget and sits on the card. NOT NARRATED: FDA clearance of this platform, the two minute and 45 minute scan times, the training data volume, the commercial availability states, the underway 3,200 patient multicenter study, the named lead research sites, and the lesion detection, 3D segmentation and lesion classification capabilities, all real page facts dropped for budget and for the no list rule. The planned multimodal extension spanning 3D ultrasound, mammography, MRI and clinical information is a four item list and a forward looking plan, and is not narrated at all. REFUSED: the CEO quotation "Getting the scan closer to the patient is the first breakthrough" is barred twice over, as a figure of speech and as an unearned superlative, and is not narrated or paraphrased. The CEO's "Our vision is to make that scan increasingly informative: helping clinicians see what is there, understand what has changed and make more informed decisions" is vendor aspiration and a three item list, and is refused. The script does not say the scan finds more cancers, improves outcomes, saves lives or is better than mammography, because the page claims none of that; "more sensitive than a handheld scan" is the page's own narrow comparison and is left exactly that narrow. The hedged page phrase "could help clinicians" is not upgraded to "helps".(SCENE 2 BACKING. Same first-party NVIDIA blog post, the section headed "Automated Imaging Delivers AI-Powered Insights" about iSono Health. The sensitivity claim is explicitly the company's own: the page writes "that the company says is 28% more sensitive". No independent audit, no regulator performance result, no peer reviewed citation and no outside reviewer is named for it anywhere on the page, and the validating multicenter study is described as still underway.)
• Backing sentences, quoted from the page: "Another NVIDIA Inception company, Whiterabbit.ai, develops AI technology for breast cancer screening. Its FDA-cleared WRDensity software automatically assesses breast density from mammograms and has been used in the care of hundreds of thousands of patients." and "The company has also developed WRRisk, a clinical decision support software for estimating patients' long-term risk of developing breast cancer, and is researching a new generation of AI for mammography that could help radiologists detect more cancers while automating the screening of mammograms that are negative for breast cancer." and "Whiterabbit trains its AI models on a cluster of NVIDIA GPUs housed at Washington University in St. Louis, supplemented by additional GPU capacity in the cloud. Inference runs on NVIDIA GPUs deployed directly in the clinic." and "Ataraxis's AI models analyze digital pathology slides and standard clinical variables to predict treatment response and recurrence risk. One model predicts whether presurgical chemotherapy is likely to shrink a patient's tumor to the point of response before the operating room. After surgery, another model estimates a patient's five-year recurrence risk and the likely benefit of chemotherapy as a next step." and "Both models have been validated across more than 10 institutions and multiple clinical trials, and are in active clinical use. They run on NVIDIA GPUs on premises, in an offsite data center and in the cloud, using PyTorch accelerated by NVIDIA CUDA throughout." and "The company builds AI-powered precision medicine technology that creates accurate 3D models of breast tumors, veins and other soft tissue, delivering important insights to help guide surgeries and influence treatment plans. It has also built a tool to estimate the risk of breast cancer recurrence based on 3D volumetric data from a patient's breast MRI, tumor pathology and clinical data." EDITORIAL DECISION: three companies and roughly a dozen distinct capabilities are compressed into one sixteen word sentence carrying exactly two items, "assess breast density from mammograms" and "predict how tumors respond to treatment", joined by "and" with NO comma between them. This is the single biggest risk in this story, because the source is a four company roundup and a comma list reads at 2.65 spoken words per second against 2.18 for plain prose and will blow the sixty second ceiling even at a legal word count. Every full list, every third and fourth item and every company name is therefore carried silently on the scene card. No brand name is spoken: "Whiterabbit.ai" is a dotted domain style name, "WRDensity" and "WRRisk" are glued brand plus letter tokens, "Ataraxis AI" and "SimBioSys" are invented names, and "MONAI", "CUDA-X", "cuBLAS" and "PyTorch" are a mix of glued tokens and hyphenated compounds; all of them are high risk for our voice engine and all are confined to the silent cards. The attribution "NVIDIA says" is spoken because this is NVIDIA's account of other companies' products on NVIDIA's own blog. The scene speaks no figure: the hundreds of thousands of patients, the more than 10 institutions and the five year recurrence window are all digits on the card. NOT NARRATED: FDA clearance of the density software, the hundreds of thousands of patients it has been used for, the long term risk tool, the research stage mammography work, the NVIDIA GPU cluster at Washington University in St. Louis, in clinic inference, the presurgical chemotherapy model, the post surgical five year recurrence and chemotherapy benefit model, the validation across more than 10 institutions and multiple clinical trials, active clinical use, the on premises and offsite and cloud deployment, the 3D tumor and soft tissue models, the MRI based recurrence tool, and the October 1 Breast Cancer Awareness Month panel in Phoenix, Arizona are all real page facts dropped from narration for word budget, for the no list rule and for the no spoken date rule. REFUSED: the Whiterabbit CTO quotation is barred in every form, specifically "needle-in-a-haystack problem", "a powerful sidekick to radiologists", "helping to clear away the hay" and "where it matters most", and none of it is paraphrased into a new figure of speech. The page's section heading "Finding Cancers, Cutting False Alarms" is a claim the page does not evidence and is not narrated. The Ataraxis quotation's competitive framing, that the tools oncologists rely on today "were largely trained once, fifteen years ago, and never updated", is a vendor's characterisation of rival products and is refused; the SimBioSys CEO's "it generates new insights beyond what we had from any individual piece" and "patients and physicians need answers quickly. They can't afford to wait days or weeks" are vendor marketing and urgency framing and are refused. The page's adjective meaning agent like, which appears in its Related News list, is barred from this file in every form because our voice engine garbles it in all four prompt configurations. The vendor adjectives "accurate" and "important insights" are not narrated. Nothing is narrated about detecting more cancers: that capability is described by the page as still being researched, and the script says nothing about it.(SCENE 3 BACKING. Same first-party NVIDIA blog post, the sections headed "Finding Cancers, Cutting False Alarms" about Whiterabbit.ai, "Predicting Which Treatments Will Work" about Ataraxis AI, and "Providing Tumor Insights With 3D Visualization" about SimBioSys. All three are described by the page as NVIDIA Inception companies running on NVIDIA GPUs and NVIDIA software. Every capability and validation statement in these sections is the company's own or NVIDIA's own account of it; no outside auditor, journalist, regulator result or peer reviewed citation is named for any of them on the page.)
• Backing facts, confirmed by reading the whole document as captured at 2026-10-05T13:11:43.908Z. Publisher and authorship are stated by the page itself: the byline reads "by Chelsea Sumner", and the page describes her as "Chelsea Sumner, healthcare AI startups lead for North and Latin America at NVIDIA". Program ownership is stated repeatedly: "Companies in the NVIDIA Inception program for startups are building AI applications", "NVIDIA Inception startup iSono Health", "Another NVIDIA Inception company, Whiterabbit.ai", "Another NVIDIA Inception company, SimBioSys, joined NVIDIA on a recent panel marking Breast Cancer Awareness Month", and the closing call to action "Learn more about the NVIDIA Inception program for startups." Commercial dependence on NVIDIA hardware and software is stated for all four: "accelerated by NVIDIA AI infrastructure", "It uses NVIDIA GPU acceleration and open source medical imaging technology", "Whiterabbit trains its AI models on a cluster of NVIDIA GPUs", "Inference runs on NVIDIA GPUs deployed directly in the clinic", "They run on NVIDIA GPUs on premises, in an offsite data center and in the cloud, using PyTorch accelerated by NVIDIA CUDA throughout", and "SimBioSys uses NVIDIA MONAI for training and validation data, and NVIDIA CUDA-X libraries including cuBLAS and MONAI Deploy for its imaging technology, which runs on NVIDIA GPUs in the cloud." Vendor supplied provenance of the headline performance number is explicit in the page's own wording: "a 3D scan that the company says is 28% more sensitive than a handheld 2D ultrasound". The investigational disclaimer is quoted verbatim: "Certain technologies described in this article are investigational and have not been approved by the U.S. FDA for commercial use." The page carries no table, no chart, no sample size, no date range, no confidence interval and no methodology for any figure on it. EDITORIAL DECISION: scene 4 is spent entirely on who is making these statements and on what this Short actually read, because that is the central editorial fact of a chip vendor publishing a roundup of startups in its own program that buy its hardware. It is three sentences totalling forty one words, each one a single plain provenance fact with no comma list: that these companies are in NVIDIA's own program and run on hardware NVIDIA sells, that the companies supplied their own performance claims and that this video read only that blog post, and that NVIDIA says some of this technology is investigational and not approved for commercial use. "We read only that blog post" is a literal statement about this production: only the captured article.txt was read. The linked NVIDIA Inception program page, the embedded ATUSA_software_show_10s.mp4 asset, the GTC Berlin registration page and every item in the Recent News and Related News lists were all left unfetched, so this script makes no claim about any figure, capability or approval status that is not in the captured text. The scene speaks no figure and no date, which keeps the script's only number, in scene 1, three sentences away from the close. "FDA" is deliberately NOT spoken: the narration says "not approved for commercial use" in plain words and the verbatim disclaimer including "U.S. FDA" sits on the silent card, because a gate prefers plain wording over initialisms and "U.S." would have to be spoken as "the United States", costing words this budget does not have. No criticism is invented. The 28% and every other vendor figure is not called false, inflated or misleading; NVIDIA and the four companies are not accused of hiding anything; no motive is attributed to anyone; and the word "marketing" does not appear in any narrated line. Provenance facts only. The medicine is deliberately not overstated: no narrated line calls any of this a cure, a breakthrough, a proven survival benefit or an improvement in outcomes, and the script makes no claim that any of it detects more cancers or helps any patient live longer, because the page evidences none of that. REFUSED: no countdown, urgency or deadline phrasing appears in any field of this file, because a downstream validator hard fails those phrases; the GTC Berlin "Register Now" and "October 20-22" furniture was excluded for that reason as well as because it is advertising aimed at NVIDIA's readers. No second person hype and no rhetorical question appears in any copy field. No em dash, en dash or double hyphen appears in any field, and the source's own em dashes were rewritten wherever source text is quoted above. The page's framing that the companies are "addressing both ends of that gap, and everything in between" is a figure of speech and is refused, as are "At the other end of the care timeline" and "From Scan to Treatment Plan". MANAGER SPLIT, recorded for the audit trail: this provenance passage was authored as a single 41 word scene 4 and was split into scene 4 and scene 5 by the manager because a QA gate caps each scene narration at 30 words. Not one narrated word was added, removed or reordered: scene 4 keeps the first two sentences and scene 5 carries the third sentence verbatim, so the script total stays 115 narrated words and 10 sentences. The scene 4 on-screen card was split on the same line, with the page disclaimer moved to the scene 5 card and quoted in full there. The cosmetic planning integers were split 7 plus 5, so the four plus one scene total stays 40. Scene 5 speaks no figure, which keeps the script single spoken figure in scene 1 clear of the closing sentences.(SCENE 4 BACKING (sentences one and two of the provenance passage), MANDATORY DISCLOSURE. The page itself is the evidence. A first-party post on NVIDIA's own corporate blog, written by NVIDIA's own healthcare AI startups lead for North and Latin America, about four companies in NVIDIA's own Inception startup program, every one of which the page says runs on NVIDIA GPUs and NVIDIA software that NVIDIA sells. Every performance claim on the page is supplied by the company that benefits from it, and the page names no independent audit, no regulator result, no journalist and no outside reviewer anywhere. The page also carries its own investigational disclaimer. This is not a product launch: NVIDIA announced nothing of its own here.)
• Backing sentence, quoted verbatim from the foot of the page: "Certain technologies described in this article are investigational and have not been approved by the U.S. FDA for commercial use." The page separately states that two named products ARE already cleared: "The company's FDA-cleared ATUSA platform" and "Its FDA-cleared WRDensity software". EDITORIAL DECISION: the disclaimer is narrated because a viewer hearing about cancer imaging and treatment prediction software will otherwise assume every product described is approved and in routine use, and the page itself says that is not true of all of them. The narration is hedged exactly as the page hedges it, with "some of this technology", because the page does not say which items are investigational and this script will not guess. "FDA" is not spoken: the voice engine is unreliable on short glued letter tokens, so narration says "not approved for commercial use" and the silent card carries the disclaimer verbatim including "U.S. FDA". The scene is attributed with "NVIDIA says" because it is NVIDIA's own statement on NVIDIA's own page. The scene speaks no figure. NOT NARRATED: which specific products are FDA cleared and which are investigational, and the fact that two products are already cleared, are real page facts carried silently on the card so that the narration neither overstates approval nor wrongly implies that nothing here is cleared. REFUSED: the script does not say any product is unsafe, does not say any product was rejected by a regulator, does not predict any approval, and does not attach any timeline to approval, because the page supports none of that. MANAGER SPLIT, recorded for the audit trail: this provenance passage was authored as a single 41 word scene 4 and was split into scene 4 and scene 5 by the manager because a QA gate caps each scene narration at 30 words. Not one narrated word was added, removed or reordered: scene 4 keeps the first two sentences and scene 5 carries the third sentence verbatim, so the script total stays 115 narrated words and 10 sentences. The scene 4 on-screen card was split on the same line, with the page disclaimer moved to the scene 5 card and quoted in full there. The cosmetic planning integers were split 7 plus 5, so the four plus one scene total stays 40. Scene 5 speaks no figure, which keeps the script single spoken figure in scene 1 clear of the closing sentences.(SCENE 5 BACKING, MANDATORY DISCLOSURE (sentence three of the provenance passage). The page own disclaimer, printed by NVIDIA at the foot of its own post. This is the publisher stating the regulatory status of the technologies it just described, so it is first party but it is an admission against interest rather than a promotional claim.)
• No source sentence backs the endcard. It is the standard Inboxsmith pitch, "Inboxsmith builds AI receptionists for small business. Please like and subscribe for more news." EDITORIAL DECISION: the endcard carries no NVIDIA claim, no company name, no medical claim, no approval or clearance statement and no figure of any kind, so no vendor assertion and no health assertion is spoken at the point where narration stops attributing. Keeping it figure free also keeps the script's single spoken figure, in scene 1, five sentences clear of the close, so no two figures can land in adjacent sentences at the end of the read. The two required sentences are present verbatim, including both periods, and "Please like and subscribe for more news." is the final sentence of the whole script. endcard.onscreen is exactly "inboxsmith.com". No countdown, deadline or urgency phrasing and no rhetorical question appears here.(ENDCARD. Inboxsmith house sign off. Carries no claim from the source and is deliberately not traceable to the article.)
• No corroboration of any kind was obtainable, so this single NVIDIA blog post is the sole source for every narrated claim. Recorded plainly, from the files themselves: the YouTube transcript pull returned 0 of 5 videos, because the yt-dlp build installed on this box is too old to fetch captions. That is a known local tooling limitation, not bot blocking, and it says nothing about the story. transcripts.json for this slug holds an empty videos array with fetchedAt 2026-10-05T13:15:51.054Z, so not one sentence of transcript text was available to check anything against, and sources.json for this slug holds an empty sources array, which is normal for this pipeline and is not a red flag. Because any claim absent from article.txt would require two or more independent transcript confirmations and there are zero transcripts, every narrated claim in this script comes from article.txt and nothing else, and nothing was inferred, estimated, averaged or filled in. The twelve dated probes in timeline-probes.json, fetchedAt 2026-10-05T13:15:52.027Z, were read in full for weak existence context only and not one word of them is narrated. They are unrelated and mostly old noise: a 2020-10-06 KX News local Breast Cancer Awareness segment, a 2021-05-12 WOSU Public Media health and AI interview, a 2021-10-25 Hologic marketing clip for its own mammography reading product, a 2023-01-06 BloomAlert clip about Google and DeepMind releasing a medical language model, a 2023-06-10 consumer clip about the Temu shopping app, a 2023-08-03 AI Daily Brief clip about leaked image generator samples, a 2024-09-05 Australian daily trends clip about a celebrity breast cancer story, a 2024-12-10 SpokenLayer tech news roundup about ByteDance and Apple litigation, a 2025-02-03 AI Brief episode on European Union AI Act enforcement, a 2026-03-17 clip about a gaming graphics upscaler, a 2026-10-01 NBC News daily news programme, and a 2026-10-03 Orlando lifestyle show whose title merely lists "Breast Cancer AI" among three unrelated local segments. NOT ONE of the twelve probes is this story: none mentions NVIDIA Inception, none mentions any of the four companies profiled here, and none mentions this blog post, so this is genuinely new coverage rather than a re-promotion of an older feature, and the same day NEW framing is honest. The freshness wording is deliberately accurate for a same day item that is NOT a launch: NVIDIA published a blog post today about companies and products that already exist, several of which the page says are FDA cleared and commercially available while others it says are investigational, so no narrated line says "just launched", "just announced", "released today" or anything equivalent. The closest the script comes to a time claim is "The post appeared on NVIDIA's own blog", which is about the post, not about any product. No timeline block is included in this file on purpose, because resolveEventDate prefers the earliest timeline date over storyDate, and with a 2020 dated probe in the set a timeline array would wrongly age a same day story into the CATALOG tier; storyDate is 2026-10-05, the post's own date, which is also the capture date and the production date. NOT A DUPLICATE, verified against our own production directory and our cross-post registry and recorded here: the production tree holds 357 slug directories as checked at authoring time, including this one, and nvidia-ai-breast-cancer is the ONLY slug matching breast, mammography, cancer, iSono, Whiterabbit, Ataraxis or SimBioSys in any form. We have published two other NVIDIA healthcare Shorts, nvidia-medical-physics-simulation and nvidia-open-source-ai-cardiac-care, and both are different stories on different subjects, medical physics simulation and cardiac care respectively; neither covers breast cancer, mammography, breast ultrasound, breast density, digital pathology or any of the four companies named here. Nothing on this subject has been produced before. SECURITY NOTE: article.txt, transcripts.json and timeline-probes.json were treated as untrusted data and used as a fact source only. article.txt contains no instruction directed at the author of this script, and nothing in it was followed. It does contain ordinary reader facing imperative page furniture and advertising, and all of it was recognised as such and ignored: the accessibility link "Skip to content", the sharing widgets "Share", "Share This Article", "Copy link", "Link copied!", the X, Facebook and LinkedIn share buttons, the footer "Share This" block, and "Share on Mastodon" with its input prompt "Enter your Mastodon instance URL (optional)" and a second "Share" button; the event advertisement "NVIDIA GTC Berlin Registration Is Now Open", "October 20-22" and "Register Now"; the in body call to action "Learn more about the NVIDIA Inception program for startups."; the navigation item "View All Recent News"; and the Recent News and Related News link lists, which carry four and four unrelated NVIDIA headlines respectively, among them a DGX Spark 64GB developer story dated October 2, 2026, a GPT-6 acceleration story dated October 1, 2026, a GeForce NOW games story dated October 1, 2026, an AI factories return on investment story dated October 1, 2026, a CoreWeave story dated September 30, 2026, an NVIDIA Life staff profile dated September 23, 2026 and an MLPerf Inference v6.1 story dated September 16, 2026. None of that was treated as an instruction, none was followed, no linked page was fetched, no embedded media file was fetched, and none of it is narrated. The "0 Comments" counter, the category and tag lists and the " " and "’" HTML entities in the capture were recognised as page furniture and markup artefacts, not as content.(CORROBORATION STATUS: NONE)